Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms NR-6a |
Target |
Action degraders |
Mechanism MAPK11 degraders(mitogen-activated protein kinase 11 degraders), p38α degraders(P38 α mitogen-activated protein kinase degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC50H55BrF2N8O7 |
InChIKeyDYERNVOWSSIIQF-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Spain | 18 Jun 2020 |